Glycine

We are Glycine CAS:56-40-6 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name: Glycine
CAS.NO:  56-40-6
Synonyms:
carboxymethylamine
Glycine
2-aminoacetic acid
aminomethylcarboxylic acid

Molecular Formula: C2H5NO2
Molecular Weight:  75.06660

Physical and Chemical Properties:
Density: 1.595 g / cm3
Boiling point: 233ºC at 760 mmHg
Melting point: 240° C
Flash point: 145ºC
Refractive index: 1.461

Specification:
Appearance: White crystalline powder
Purity:≥99.0%
PH（5% in water）: 5.5～6.5
Heavy metals (as Pb) : ≤0.002%
Loss on drying: ≤0.2%
Iron (as Fe): ≤0.001%
Residue on ignition: ≤0.1%
Chloride (as Cl): ≤0.007%
Ammonium (as NH4): ≤0.02%
Sulphate (as SO4): ≤0.006%
Lead (as Pb): ≤0.001%
Arsenic (as As): ≤0.0001%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Glyphosate CAS:1071-83-6

Related News: Biogen last month revived its plans to seek U.S. approval for its aducanumab treatment after announcing in March that it would terminate two large clinical trials for the drug. But some analysts believed FDA approval is highly unlikely.4-Bromodiphenylamine INSPIRE is a global, multi-center, randomized, controlled study to assess the efficacy and safety of IV rigosertib in higher-risk MDS (HR-MDS) patients who had progressed on, failed to respond to, or relapsed after previous treatment with a hypomethylating agent (HMA) within nine cycles over the course of one year after initiation of HMA treatment.trans-1,4-Dibromo-2-butene INSPIRE is a global, multi-center, randomized, controlled study to assess the efficacy and safety of IV rigosertib in higher-risk MDS (HR-MDS) patients who had progressed on, failed to respond to, or relapsed after previous treatment with a hypomethylating agent (HMA) within nine cycles over the course of one year after initiation of HMA treatment.Decyl(trimethoxy)silane CAS:5575-48-4 INSPIRE is a global, multi-center, randomized, controlled study to assess the efficacy and safety of IV rigosertib in higher-risk MDS (HR-MDS) patients who had progressed on, failed to respond to, or relapsed after previous treatment with a hypomethylating agent (HMA) within nine cycles over the course of one year after initiation of HMA treatment.The drug substance is an active product that has completed the synthetic route, and the intermediate is a product in one place in the synthetic route.